Literature DB >> 22435608

Chemistry and biology of multicomponent reactions.

Alexander Dömling1, Wei Wang, Kan Wang.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22435608      PMCID: PMC3712876          DOI: 10.1021/cr100233r

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  241 in total

Review 1.  Targeting protein-protein interactions for cancer therapy.

Authors:  David C Fry; Lyubomir T Vassilev
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

2.  Multicomponent synthesis of 2-imidazolines.

Authors:  Robin S Bon; Bart van Vliet; Nanda E Sprenkels; Rob F Schmitz; Frans J J de Kanter; Christian V Stevens; Marcel Swart; F Matthias Bickelhaupt; Marinus B Groen; Romano V A Orru
Journal:  J Org Chem       Date:  2005-04-29       Impact factor: 4.354

3.  The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor.

Authors:  S E Zographos; N G Oikonomakos; K E Tsitsanou; D D Leonidas; E D Chrysina; V T Skamnaki; H Bischoff; S Goldmann; K A Watson; L N Johnson
Journal:  Structure       Date:  1997-11-15       Impact factor: 5.006

4.  Discovery of small molecule human C5a receptor antagonists.

Authors:  Hitesh J Sanganee; Andrew Baxter; Simon Barber; Alastair J H Brown; Denise Grice; Fraser Hunt; Sarah King; David Laughton; Garry Pairaudeau; Bob Thong; Richard Weaver; John Unitt
Journal:  Bioorg Med Chem Lett       Date:  2008-12-31       Impact factor: 2.823

5.  A four component coupling strategy for the synthesis of D-phenylglycinamide-derived non-covalent factor Xa inhibitors.

Authors:  Scott M Sheehan; John J Masters; Michael R Wiley; Stephen C Young; John W Liebeschuetz; Stuart D Jones; Christopher W Murray; Jeffrey B Franciskovich; David B Engel; Wayne W Weber; Jothirajah Marimuthu; Jeffrey A Kyle; Jeffrey K Smallwood; Mark W Farmen; Gerald F Smith
Journal:  Bioorg Med Chem Lett       Date:  2003-07-21       Impact factor: 2.823

6.  Application of multicomponent reactions to antimalarial drug discovery. Part 3: discovery of aminoxazole 4-aminoquinolines with potent antiplasmodial activity in vitro.

Authors:  Chitalu C Musonda; Susan Little; Vanessa Yardley; Kelly Chibale
Journal:  Bioorg Med Chem Lett       Date:  2007-06-27       Impact factor: 2.823

7.  A resource-efficient and highly flexible procedure for a three-component synthesis of 2-imidazolines.

Authors:  Niels Elders; Rob F Schmitz; Frans J J de Kanter; Eelco Ruijter; Marinus B Groen; Romano V A Orru
Journal:  J Org Chem       Date:  2007-07-12       Impact factor: 4.354

8.  One-pot synthesis of diverse 4-di(tri)fluoromethyl-3-cyanopyridine-2(1H)-thiones and their utilities in the cascade synthesis of annulated heterocycles.

Authors:  Lyudmila A Rodinovskaya; Anatoliy M Shestopalov; Anna V Gromova; Alexander A Shestopalov
Journal:  J Comb Chem       Date:  2008-02-13

9.  Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel.

Authors:  Ricardo De La Fuente; Wan Namkung; Aaron Mills; A S Verkman
Journal:  Mol Pharmacol       Date:  2007-12-14       Impact factor: 4.436

Review 10.  Emerging molecular diversity from the intra-molecular Ugi reaction: iterative efficiency in medicinal chemistry.

Authors:  Christopher Hulme; Justin Dietrich
Journal:  Mol Divers       Date:  2009-02-11       Impact factor: 3.364

View more
  204 in total

1.  REGIOSELECTIVE MULTICOMPONENT DOMINO REACTIONS PROVIDING RAPID AND EFFICIENT ROUTES TO FUSED ACRIDINES.

Authors:  Jin-Peng Zhang; Wei Fan; Jie Ding; Bo Jiang; Shu-Jiang Tu; Guigen Li
Journal:  Heterocycles       Date:  2013-12-17       Impact factor: 0.831

Review 2.  Focusing on shared subpockets - new developments in fragment-based drug discovery.

Authors:  Eman M M Abdelraheem; Carlos J Camacho; Alexander Dömling
Journal:  Expert Opin Drug Discov       Date:  2015-08-21       Impact factor: 6.098

3.  Construction of functionalized tricyclic dihydropyrazino-quinazolinedione chemotypes via an Ugi/N-acyliminium ion cyclization cascade.

Authors:  Steven Gunawan; Christopher Hulme
Journal:  Tetrahedron Lett       Date:  2013-08-14       Impact factor: 2.415

4.  An efficient three-component synthesis of highly functionalized tetrahydroacenaphtho[1,2-b]indolone derivatives catalyzed by L-proline.

Authors:  Juan-Juan Zhang; Xian Feng; Xue-Cheng Liu; Zhi-Bin Huang; Da-Qing Shi
Journal:  Mol Divers       Date:  2014-08-24       Impact factor: 2.943

5.  Toward the Ideal Synthesis and Transformative Therapies: The Roles of Step Economy and Function Oriented Synthesis.

Authors:  Paul A Wender
Journal:  Tetrahedron       Date:  2013-06-07       Impact factor: 2.457

6.  Isocyanide-Based Multicomponent Reactions of Free Phenylboronic Acids.

Authors:  Constantinos G Neochoritis; Tryfon Zarganes-Tzitzikas; Michaela Novotná; Tatiana Mitríková; Zefeng Wang; Katarzyna Kurpiewska; Justyna Kalinowska-Tłuścik; Alexander Dömling
Journal:  Eur J Chem       Date:  2019-08-15

7.  Synthesis of some new triamide derivatives via Ugi five-component reaction in aqueous solution.

Authors:  Ali Asghar Mohammadi; Salman Taheri; Arman Amini; Reza Ahdenov
Journal:  Mol Divers       Date:  2018-06-27       Impact factor: 2.943

8.  Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods.

Authors:  Edwin Kroon; Jörg O Schulze; Evelyn Süß; Carlos J Camacho; Ricardo M Biondi; Alexander Dömling
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-04       Impact factor: 15.336

9.  Four-component strategy for selective synthesis of azepino[5,4,3-cd]indoles and pyrazolo[3,4-b]pyridines.

Authors:  Bo Jiang; Qin Ye; Wei Fan; Shu-Liang Wang; Shu-Jiang Tu; Guigen Li
Journal:  Chem Commun (Camb)       Date:  2014-06-11       Impact factor: 6.222

Review 10.  Tetrazoles via Multicomponent Reactions.

Authors:  Constantinos G Neochoritis; Ting Zhao; Alexander Dömling
Journal:  Chem Rev       Date:  2019-02-01       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.